While there is a lack of research on whether FGF21 can affect the progression of DN by regulating the cell cycle in diabetic nephropathy, this article is based on this to explore the novel mechanism of FGF21 in the treatment of diabetic nephropathy. This evidence concerns the gene FGF21 and liver dysplastic nodule.